Does Dr. GREISHA GONZALEZ SANTIAGO have financial conflicts of interest?

Dr. GREISHA GONZALEZ SANTIAGO (MD) has received a total of $6,723 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $6,723 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. GREISHA GONZALEZ SANTIAGO?

According to CMS Open Payments data, Dr. GREISHA GONZALEZ SANTIAGO received funding from ASTRAZENECA PHARMACEUTICALS ($1,820), BOEHRINGER INGELHEIM PHARMACEUTICALS ($854), and GLAXOSMITHKLINE ($639).

Does Dr. GREISHA GONZALEZ SANTIAGO receive research grants or speaking fees?

Dr. GREISHA GONZALEZ SANTIAGO has received $6,723 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. GREISHA GONZALEZ SANTIAGO

MDReal-Time Hydrated

Specialty: Hospitalist

Practice Location: PONCE, PR 00728

NPI Number: 1275047052

LIFETIME INDUSTRY VALUE

$6,723

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. GONZALEZ SANTIAGO is a verified Hospitalist practitioner based in PONCE, PR.

Between 2021 and 2025, Dr. GONZALEZ SANTIAGO had an overall industry promotional and research financial footprint of $6,723 as recorded in the federal CMS Open Payments database.

$6,723 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. GONZALEZ SANTIAGO's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $1,820 (representing 27.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$1,820

27.1%

BOEHRINGER INGELHEIM PHARMACEUTICALS

Rank 2

$854

12.7%

GLAXOSMITHKLINE

Rank 3

$639

9.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.